Antibiotics. Learning Outcomes Understand the causes of infections Know about the Classification of...

Post on 28-Dec-2015

212 views 0 download

Tags:

transcript

Antibiotics

Learning Outcomes

• Understand the causes of infections• Know about the Classification of Antibacterial agents• Understand what Factors guide Antibiotic Choice• Know and understand key concepts about the following

antibiotics:• Penicillins• Cephalosporins• Macrolides• Tetracyclines• Aminoglycosides• Quinolones• Metronidazole

Definitions

• Antibiotic, antibacterial, antimicrobial, anti-infectives, anti-fungals, anti-virals

• BNF classification

• Natural, semi synthetic and synthetic

Importance

• Host immune system

• Resistance

Causes of infections

• 3 types of micro-organisms:

• Bacteria

• Fungi

• Viruses

• Give an example of a disease caused by each of the above

Identification of Bacterial Organisms

• Gram staining is a basic microbiologic procedure for detecting and identification of bacteria.

• The main structural component of cell wall is peptidoglycan.

• Peptidoglycan and cell wall structural differences form the basis of the different staining properties.

• With Gram staining:– Gram +ve stain purple– Gram –ve stain pink

• Why is Gram staining important?• Cell shapes(cocci/rods)• Aerobic/anaerobic

Gram Positive and Negative organisms

• What is a Gram stain?• Gram positive organisms:

– Staphylococcus aureus (cocci)– Streptococcus pneumoniae (diplcocci)– Coagulase negative staphylococcus (cocci)

• Gram negative organisms:– Escherichia coli (rods)– Klebsiella pneumoniae– Pseudomonas aerguinosa– Salmonella typi (rods)– Neisseria meningitidis (diplococci)

Factors guiding Antibiotic Choice

– The presumed site of infection– Positive microbiological culture results– Suspected or known organisms – Resistance patterns of the common microbial flora. – Properties of the antibiotic: e.g. route of

administration, pharmacokinetic aspects– Patient’s health status:

e.g. immune status (especially neutropenia and immunosuppressive drugs), allergies, renal dysfunction, and hepatic dysfunction

Choosing An Antibiotic

• Cost

• Local resistance

• Environment

• Patient factors

• Site

Choosing An Antibiotic

• BACTERIAL FACTORS- Use only for bacterial infections- Identify bacteria involved, or best guess

HOST FACTORS- site, route, allergies, renal function, hepatic

function, pregnancy

DRUG FACTORS

- activity, site,bactericidal/bacteriostatic route, cost

Classification of Antibacterial agents

• main ways:– Whether they are bacteriostatic or bactericidal– By target site– By chemical structure– Bacterial spectrum

• targets for antibacterials:– Cell wall synthesis– Protein synthesis– DNA synthesis– Metabolic pathways

Selective Toxicity

• Kill/harm micro-organism without harming host organism

• Antibiotics-> high therapeutic index

• TI = toxic dose/therapeutic dose

Aspects of antibiotics

• Method of action – bactericidal/bacteriostatic

• Spectrum of activity

- Broad

- Narrow

Penicillins

• Bactericidal agents• Contain a β-lactam ring in structure.• They inhibit synthesis of the bacterium cell wall by

affecting synthesis of peptidoglycan.• Peptidoglycan cell wall surrounds certain bacteria and is

essential for their survival.• This results in dividing cells not being able to maintain

the osmotic gradient.• Net effect is cell swelling, rupture and death of the

bacterium.

Penicillins

• Spectrum:– Aerobic Gram +ve – Gram –ve cocci– Many anaerobic micro-organisms– Not all penicillins are considered broad

spectrum antibiotics

Benzylpenicillin or Penicillin G

• Very poor oral absorption• Given IV or IM (single doses > 1.2g IV

route only)• High Na+ content 1.68mmol/600mg vial,

3.36mmol/3.2g vials.• Slow IV injection or infusion over 30-60

minutes.

Benzylpenicillin

• Unwanted effects:– Allergic reaction in up to 10% of exposed individuals– Anaphylaxis less common in 0.05%– Immediate anaphylaxis, urticaria, rash after penicillin

administration should not receive penicillin.– Minor rash >72 hrs after exposure is probably not a true allergy– Those allergic to one penicillin are allergic to all

• Elimination:– Renal excretion– Rapid, short half life– Dose reduced in severe renal impairment

Amoxicillin/Ampicillin

• Broad spectrum• Use e.g. community acquired respiratory tract

infections- H Influenza and S. Pneumoniae• Renal excretion• Amoxicillin preferred oral route

Co-amoxiclav

• Consists of amoxicillin combined with a beta-lactamase inhibitor clavulanic acid

• Spectrum:– Active against Gram-ve rods resistant to amoxicillin

due to beta-lactamases– E.g. resistant strains of E.coli, S. aureus and H.

influenzae.– Clavulanic acid has no antibacterial activity

Flucloxacillin

• Bactericidal antibiotic• A beta-lactamase-resistant penicillin• Used for penicillin-resistant staphylococci.• Can be less effective against bacterium that

does not produce beta-lactamase• It is less active against Streptococcus

pneumoniae and Str. pyogenes than penicillin.

Flucloxacillin

• IV dose: 0.25-2g every 6 hours• Elimination:

– Mainly renally excreted as unchanged drug– Small extent of metabolism

• Unwanted effects:– Hypersensitivity as in penicillin– Hepatitis & cholestatic jaundice were reported several weeks

after treatment was stopped.– Risk factor are increasing age and > 2weeks treatment.

Cephalosporins

• Bactericidal agents• Semi-synthetic antibiotics, related to penicillins

and contain β-lactam ring.• Some are susceptible to β-lactamase activity, so

less activity against staphylococcal infections.• β-lactamase are enzymes that catalyse the

hydrolysis of beta-lactam, resulting in loss of antibacterial activity.

Cephalosporins

• 1st, 2nd 3rd generation• Mostly given IV, IM, except cefalexin(1st gen.) and

cefuroxime(2nd gen.) • They distribute into many tissues.• Spectrum:

– Second line in many infections– Broad spectrum antibiotics– Generally 3rd generations have higher activity against Gram –ve

bacterium, but less activity against Gram +ve ones.

Cephalosporins

• Unwanted effects:– Hypersensitivity reactions.– 10% of penicillin-sensitive patients are also allergic to

cephalosporins– 2nd & 3rd generation higher risk of infection with

Clostridium difficile

• Elimination:– Mainly renal via tubular secretion– Some like 40% ceftriaxone in bile

Macrolides

• E.g. erythromycin, clarithromycin.• Similar antibacterial spectrum to penicillins• Mechanism: inhibit bacterial protein synthesis by

binding to bacterial ribosome.• Bacteriostatic• Can be effective against unusual organisms

Macrolides

• Generally safe drugs• Erythromycin can cause gastrointestinal

problems which are less common with other agents.

• Azithromycin has a long half life• Macrolides can inhibit cytochrome P450 leading

to accumulation of drugs.

Tetracyclines

• E.g. tetracycline, doxcycline• Mechanism inhibit protein synthesis• Absorption of tetracyclines is affected by calcium and

magnesium ions, food and iron preparations.• Broad spectrum antibiotics• Bacteriostatic• Should be avoided in pregnancy, breast feeding and

children under 12 years as they bind to calcium in growing bones and teeth causing discoloration.

Aminoglycosides

• These include: gentamicin, streptomyocin, , neomycin.

• They resemble each other in:– Antibacterial activity– Pharmacokinetic properties– toxicity

Aminoglycosides

• Mechanism:– Bactericidal activity– Inhibit bacterial protein synthesis– They do this by binding to the 30S ribosomal

subunit.– They stop the translation of mRNA into the

proteins.

Aminoglycosides

• Spectrum:– Many Gram-ve (Including Pseudomonas)– Some Gram+ve – Inactive against anaerobes– Used in serious Gram –ve infections in combination

with agents that disrupt cell wall synthesis (e.g. penicillin)

– Synergistic effect with penicillin– Not absorbed orally so only given IM or IV.

Aminoglycosides

• Elimination:– Renally by glomerular filtration– In renal impairment accumulation occurs

rapidly– Result is an increase in toxicity (ototoxicity

and nephrotoxicity)– Dose adjustment is essential in renal

impairment

Aminoglycosides

• Unwanted effects:– Serious effects that are dose related.

• Ototoxicity:– Progressive damage to sensory cells– Result can be irreversible: vertigo, loss of balance,

auditory disturbances, deafness.– Effect is increased by ototoxic drugs e.g. loop

diuretics.

Aminogylcosides

• Nephrotoxicity:– Due to damage to kidney tubules which can be

reversed by stopping the drug– Risk factors:

• Pre-existing renal damage• Reduced urine output• Concomitant use of nephrotoxic drugs (administer far apart if

possible)• elderly

• Monitoring of plasma levels is necessary

Quinolones

• These include ciprofloxacin, levofloxacin.• Spectrum of activity may differ between agents.• Active against aerobic G – but not active against

anaerobes• Use: prostate, UTI, respiratory• Mechanism:

– Bactericidal– Inhibition of replication of bacterial DNA– They block the action of the enzyme DNA gyrase.– DNA gyrase is responsible for forming DNA supercoils for

replication and repair.

Quinolones

• Elimination– Hepatic metabolism– Renal excretion

• Unwanted effects– CNS effects: dizziness, headache, tremor,

convulsions.– Tendon pain and inflammation, damage and rupture,

especially in elderly and concomitant use of corticosteroids.

– Drug interactions with many agents

Metronidazole

• Spectrum– Bactericidal activity– Active against anaerobic bacteria & protozoa– Inhibit DNA synthesis and breaks down

existing DNA

Metronidazole

• Used IV, oral and rectal.• Elimination:

– Metabolised by the liver

• Unwanted effects;– Nausea and vomiting– Metallic taste– Disulfiram-like reaction when taken with alcohol

Trimethoprim

• Mechanism• Inhibits enzyme – DHFR• DHFR = dihydrofolate reductase• Folate-> dihydrofolate->tetrahydrofolate->

DHFR-> DNA synthesis• Bacteriostatic• Spectrum: E Coli+ most urinary pathogens• Narrow spectrum (inactive against anaerobes)• 1st line UTI• oral

Antibiotic Resistance

• Innate -

• Acquired

• 3 main biochemical mechanisms of acquired resistance

)a bacterial permeability to an antibiotic

b) Bacterial enzymes

c) Altered target site for antibiotic

Revision Mechanisms

• Inhibition of cell wall synthesis

• Inhibition of bacterial protein synthesis

• Inhibition of bacterial DNA synthesis

• Inhibition of metabolic pathway (e.g.folate) synthesis

1) Inhibition of cell wall synthesis

• Beta Lactams – 3 major classes

1) Penicillins

2) Cephalosporins

3) Carbapenems

1) Inhibition of cell wall synthesis

• No cell wall in mammals/present in bacteria

• Peptidoglycan • Beta lactam ring• Bactericidal• High therapeutic index• Mainly excreted in kidney• Safe in pregnancy

2) Inhibition of bacterial protein synthesis

• Inhibition of ribosomal protein synthesis• Formation of amino acids:• Gene transcription-> messengerRNA->

ribosomes-> translation-> amino acids->proteins• Antibiotics bind to bacterial ribosome• Selective toxicity• Ususally bacteriostatic but aminoglycosides-

cidal• Macrolides, aminoglycosides, tetracyclines,

3) Inhibition of bacterial DNA synthesis

• Bactricidal

• Selective toxicity – mammals do not contain DNA gyrase

• Quinolones, metronidazole,

• Quinolones: Inhibit DNA gyrase, DNA gyrase is responsible for forming DNA supercoils for replication and repair.

4) Inhibition of folate synthesis

• DNA requires folate

• Folate-> tetrahydrofolate-> DNA

• Inibition of enzyme DHFR(DHF->THF_

• E.g. trimethoprim

• DHFR= dihydrofolate reductase

• DHF = dihydrofolate

• THF = tetrahydro folate

This work was produced as part of the TIGER project and funded by JISC and the HEA in 2011. For further information see: http://www.northampton.ac.uk/tiger.

This work by TIGER Project is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. Based on a work at tiger.library.dmu.ac.uk.

The TIGER project has sought to ensure content of the materials comply with a CC BY NC SA licence. Some material links to third party sites and may use a different licence, please check before using. The TIGER project nor any of its partners endorse these sites and cannot be held responsible for their content. Any logos or trademarks in the resource are exclusive property of their owners and their appearance is not an endorsement by the TIGER project.